Allergan plc, a leading global pharmaceutical company, announced that it has acquired Topokine Therapeutics, a privately held, clinical-stage biotechnology company focused on developing topical medicines for fat reduction. Under the

This content is restricted to site members. If you are an existing user, please log in. New users may register below.

Existing Users Log In